SKI Market

A+| A| A-|

Indian Indices

Sensex

77,328.19 -516.33
( -0.66%)

Global Indices

Nasdaq

49,619.91 1.93
(0.00%)

Dow Jones

7,417.79 59.68
(0.81%)

Hang Seng

62,681.30 -152.54
(-0.24%)

Nikkei 225

10,228.01 -48.94
(-0.48%)

Forex

USD-INR

94.38 -0.30
(-0.31%)

EUR-INR

110.93 -0.26
(-0.23%)

GBP-INR

128.32 -0.39
(-0.30%)

JPY-INR

0.60 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

659.0710314

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

18.03

108721.36

EPS(TTM)

Face Value()

Div & Yield %

131.92

0.76

Back

Globe Enterprises (India) consolidated net profit declines 19.84% in the December 2025 quarter

Feb 07,2026

Net profit of Globe Enterprises (India) declined 19.84% to Rs 2.02 crore in the quarter ended December 2025 as against Rs 2.52 crore during the previous quarter ended December 2024. Sales rose 5.19% to Rs 159.46 crore in the quarter ended December 2025 as against Rs 151.59 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	159.46	151.59	5
OPM %	5.72	3.88	-
PBDT	5.64	5.04	12
PBT	4.39	3.74	17
NP	2.02	2.52	-20

77,328.19 -516.33 ( -0.66%)

49,619.91 1.93 (0.00%)

7,417.79 59.68 (0.81%)

62,681.30 -152.54 (-0.24%)

10,228.01 -48.94 (-0.48%)

94.38 -0.30 (-0.31%)

110.93 -0.26 (-0.23%)

128.32 -0.39 (-0.30%)

0.60 0.00 (-0.28%)